Local startups, foreign SMEs flock to new Diagnostics Development Hub

It will turn Singapore into a global hub for diagnostics innovation.

Singapore’s first Diagnostic Development Hub was officially launched yesterday, in a bid to catalyse the growth of the biomedical research industry and establish Singapore as a global hub for diagnostics innovation and development.

The DxD Hub will serve as a cauldron to integrate expertise across various segments in the diagnostics and medical device ecosystem with the goal to accelerate the time to market for diagnostic devices and solutions.

Foreign and local SMEs are already flocking to the new center to cater to the fast growing demand for devices that will make it faster and easier for healthcare professionals to make quicker diagnosis and deliver a better treatment outcome for patients.

For example, local start-up MiRXES, spun out from technologies developed in NUS and A*STAR, will access the DxD Hub to expedite the productisation of its devices. 

Thermo Fisher Scientific has also inked a Memorandum of Understanding with DxD Hub for the co-development of molecular diagnostics tests for global diseases with a focus on Asian phenotype and Asian specific diseases. 

Korean SME Gencurix has also leveraged on DxD Hub to take the first step by establishing a diagnostics R&D and service centre in Singapore.

"The DxD Hub is committed to embrace a borderless One-Singapore approach to catalyse the growth of the industry so as to establish Singapore as a global hub for diagnostics innovation and development. Singapore is both a gateway to the rest of Asia, as well as a channel to access the international markets," said Dr Sidney Yee, Chief Executive Officer of the DxD Hub.